Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis.

BMC Cancer · 2014 · PMC4228082 · PMID 25369730

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a negative trendno p-value reported

Median overall survival was 26.8 months and 3-year survival rate 41.7% in the IRI group suggesting a negative trend compared to the OX group as well as most published survival data after complete macroscopic cytoreduction and HIPEC with other cytostatic agents or combinations [ 8 , 9 , 11 , 45 ].

also in 4,201 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.